Karyopharm Therapeutics announces proposed public offering of common stock
Karyopharm Therapeutics announced it is commencing a registered underwritten public offering of $40 million in shares of its common stock. Karyopharm has granted the underwriter a 30-day option to purchase up to $6 million in shares of its common stock. April 24, 2017